Secretory mucin MUC5AC in gastrointestinal malignancies

SR Krishn - 2016 - digitalcommons.unmc.edu
Secretory mucin MUC5AC is an extensively glycosylated high molecular weight protein that
forms a polymeric gel layer over the epithelial layers under physiological conditions, to …

Transcriptional regulation of human mucin gene MUC4 in pancreatic cancer cells

J Zhang, X Zhang, Y Zhu, Z Chen, Z Xu… - Molecular biology reports, 2010 - Springer
The human mucin gene MUC4 is overexpressed in pancreatic cancer and cancer cell lines,
while remaining undetectable in the normal pancreas, indicating its important role in …

Isoforms of MUC16 activate oncogenic signaling through EGF receptors to enhance the progression of pancreatic cancer

D Thomas, S Sagar, X Liu, HR Lee, JA Grunkemeyer… - Molecular Therapy, 2021 - cell.com
Aberrant expression of CA125/MUC16 is associated with pancreatic ductal adenocarcinoma
(PDAC) progression and metastasis. However, knowledge of the contribution of MUC16 to …

Mucins in pancreatic cancer and its microenvironment

S Kaur, S Kumar, N Momi, AR Sasson… - Nature reviews …, 2013 - nature.com
Pancreatic cancer remains a lethal malignancy with poor prognosis owing to therapeutic
resistance, frequent recurrence and the absence of treatment strategies that specifically …

Role of integrin-linked kinase in regulating the protein stability of the MUC1-C oncoprotein in pancreatic cancer cells

HL Huang, HY Wu, PC Chu, IL Lai, PH Huang, SK Kulp… - Oncogenesis, 2017 - nature.com
MUC1-C overexpression has been associated with the progression of pancreatic tumors by
promoting the aggressive and metastatic phenotypes. As MUC1 is a STAT3 target gene …

[HTML][HTML] MUC1-C Dependence for the Progression of Pancreatic Neuroendocrine Tumors Identifies a Druggable Target for the Treatment of This Rare Cancer

H Ozawa, N Haratake, A Nakashoji, T Daimon… - Biomedicines, 2024 - mdpi.com
Patients with pancreatic neuroendocrine tumors (pNETs) have limited access to effective
targeted agents and invariably succumb to progressive disease. MUC1-C is a druggable …

Pancreatic Cancer: Pursuit of Mucins from Progression to Prognosis

A Shah, SG Kisling, SK Batra - Handbook of Oncobiology: From Basic to …, 2024 - Springer
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy characterized by a
late diagnosis, poor survival, and limited treatment options. Over the past two decades …

[HTML][HTML] Targeting MUC4 in pancreatic cancer: miRNAs

N Jonckheere, F Lahdaoui, I Van Seuningen - Oncoscience, 2015 - ncbi.nlm.nih.gov
MUC4 is a type I membrane-bound mucin expressed at the apical pole of normal polarized
epithelial cells. MUC4 apomucin is characterized by a long hyperglycosylated extracellular …

Expression and localization of MUC1, MUC2, MUC5AC and small intestinal mucin antigen in pancreatic tumors

H Yamasaki, S Ikeda, M Okajima… - International …, 2004 - spandidos-publications.com
Alterations in the expression of mucin family members play an important role as well as
alterations in oncogenes and onco-suppressor genes in carcinogenesis and progression of …

MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches

DW Kufe - Oncogene, 2013 - nature.com
Abstract Mucin 1 (MUC1) is a heterodimeric protein formed by two subunits that is aberrantly
overexpressed in human breast cancer and other cancers. Historically, much of the early …